Atezolizumab for sarcoma

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 22 Mar 2018: Trial registered, NCT03474094
  2. 1 Aug 2018: Trial started, NCT03474094

The trials

NCT03474094: Clinical and Biological Activity of an Anti-PD-L1 (Atezolizumab) in Operable Localised Soft Tissue Sarcomas Patients to be Treated With Radiotherapy

State
Under way
Phase
Phase 2
People
62 taking part
Started
1 Aug 2018
Primary completion
30 Dec 2026
Arms
pre-operative radiotherapy and atezolizumab, pre-operative atezolizumab and post-operative radiotherapy
Results
None posted
  1. 22 Mar 2018: Trial registered
  2. 1 Aug 2018: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.